• Company
• Celltrion acquires Nesina and Actos from Takeda
• by Kim, Jin-Gu Apr 28, 2021 06:05am

• Company
• Generics for Eliquis have Rx amount of ₩12.7 billion
• by Kim, Jin-Gu Apr 28, 2021 06:05am

• Policy
• The government signed an additional 40 million doses
• by Kim, Jung-Ju Apr 28, 2021 06:05am

• Company
• Roche Korea’s new NMOSD treatment Enspryng is approved
• by Eo, Yun-Ho Apr 27, 2021 06:05am

• Policy
• Results of HIRA’s preemptive response to COVID-19
• by Lee, Hye-Kyung Apr 27, 2021 06:05am

• Company
• MSD virtually prohibits one-on-one product presentations
• by Apr 27, 2021 06:04am

• Policy
• The industry is paying attention to the review of generics
• by Lee, Jeong-Hwan Apr 27, 2021 06:04am

• Policy
• Generics for Pradaxa · Xarelto are scheduled to be released
• by Lee, Tak-Sun Apr 26, 2021 05:52am

• InterView
• KRPIA will introduce advanced new drugs and seek co-growth
• by Eo, Yun-Ho Apr 26, 2021 05:52am

• Company
• Hankook Korus Pharm is preparing for Sputnik V
• by Kim, Jin-Gu Apr 26, 2021 05:51am